A new study will investigate whether prenatal antibiotic use impairs breast milk immune function and disrupts neonatal gut microbiota, potentially affecting infant health. Researchers aim to assess how prolonged antibiotic exposure in late pregnancy alters breast milk IgA and neonatal immune development.
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
CHICAGO — Combining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with the standard backbone of bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (VRd) significantly improved outcomes in
June 5, 2024